News
News
Health Ingredients Japan 2026 (Hi Japan) was held October 14–16, 2026 at Tokyo Big Sight. Natural Field exhibited at Booth 2-209, headlining NMN raw material and the NF Co-loading® liposome series, and presented the NF TriSolve® health-ingredient solutions on-site, running concurrently with Food Development Japan 2026 (FIT Japan) in the same venue.
Figure 1: Hi Japan 2026 — October 14–16, 2026, Tokyo Big Sight, Booth 2-209.
Hi Japan 2026 ran October 14–16, 10:00–17:00 daily, at Tokyo Big Sight's West Halls 1·2·4 and Atrium, co-located with Food Development Japan 2026 (FIT Japan). Natural Field's booth 2-209 was situated in the health-ingredient zone.
On opening day, the team gathered in front of the Hi Japan 2026 main visual at the venue entrance and entered together; the booth was open throughout the three days. As Japan's professional trade show for health ingredients, attendees were mainly R&D, procurement, and product-development staff from food and supplement companies — conversations were fast-paced and specific. This is why our on-booth materials focused on spec sheets, assay data, and dosage-form solutions, rather than generic corporate brochures.
Figure 2: On opening day, the team gathered in front of the Hi Japan 2026 main visual at the entrance.
Booth 2-209 used a blue visual identity: the front featured the main NMN display panel, flanked by the NF Co-loading® liposome technology panel, the liposome product series, and the NF TriSolve® solution panel.
On the raw-material side, NMN (β-nicotinamide mononucleotide, CAS No. 1094-61-7) was displayed at 99.9%+ purity, high-purity with low impurities, available in both powder (bulk density 0.3–0.6 g/ml) and granules (0.6–0.8 g/ml). Also shown were NMNH, resveratrol, curcumin, CoQ10, astaxanthin, plus phosphatidylserine, fisetin, PQQ, ergothioneine, and L-theanine functional ingredients.
On the dosage-form side, the complete liposome series was on display: NMN, NAD, glutathione, CoQ10, vitamin C, resveratrol, and curcumin all have corresponding liposomal specifications, so buyers can select directly by target active.
Figure 3: Booth 2-209 on-site — main NMN panel and NF Co-loading® liposome series.
Over the three days, customers stopped by for discussions. Their questions concentrated on three areas: (1) purity and impurity control — the 99.9% NMN spec and batch test reports were asked about repeatedly; (2) dosage-form fit — flowability and bulk density of powder vs. granules directly affect capsule filling and tableting; (3) compliance and stability — the Japanese market has very specific requirements for ingredient specs, labeling, and shelf life.
The spec sheets, CoAs, and dosage-form recommendations we prepared answered these questions on the spot. Some buyers brought existing formulations to discuss inclusion-level adjustments after switching from conventional ingredients to liposomal specs — these questions are answered fastest with data, and often a single curve was enough to move to the next step.
Figure 4: Booth discussion — customers reviewing ingredient specs and dosage-form solutions on-site.
The most technically demanding part of the booth was the NF Co-loading® co-loaded liposome platform. The core comparison on the panel: compared with conventional systems, the required dosage can be reduced to 1/3, while functional performance improves 5.7x. The technology is globally patented; the patent number marked on-site is JP7028774.
These numbers are backed by two validation sets: Caco-2 cell assays verify transmembrane absorption efficiency, and animal models provide blood-concentration curves of active compounds. This logic extends to the NF TriSolve® health-ingredient solutions, forming a four-layer evidence chain — mechanistic validation, in-vivo pharmacokinetic validation, functional validation, and human trials — landing in concrete application directions such as anti-aging.
For Japanese customers, this “data-first” communication approach is highly efficient: no need to start with concepts — curves and patent numbers let them judge technical quality directly.
Figure 5: Side view of the booth — co-loaded liposome technology panel and patent JP7028774.
After the three-day show ended, inquiries collected at the booth were sorted into three categories — raw materials, dosage forms, and solutions — and moved into the follow-up process: spec sheets and CoAs are compiled and mailed per customer-requested items, samples are arranged by dosage-form needs, and joint-development projects are handed off to technical liaison.
For Natural Field, Hi Japan 2026 was a concentrated market calibration: the strict Japanese requirements for purity, dosage form, and compliance line up exactly with our two product lines — raw materials on one side, delivery technology on the other. The show is over, but the conversation has just begun. For on-booth materials or samples, contact your Natural Field sales representative directly; follow-up will be assigned by region and product category.
A: NMN (β-nicotinamide mononucleotide, CAS 1094-61-7) at 99.9%+ purity, available in powder (bulk density 0.3–0.6 g/ml) and granules (0.6–0.8 g/ml), with batch CoA provided.
A: Compared with conventional systems, required inclusion can be reduced to 1/3 while functional performance improves 5.7x. The platform is globally patented (JP7028774), validated by Caco-2 cell assays and animal pharmacokinetic models, and supports NMN, NAD, glutathione, CoQ10, vitamin C, resveratrol, curcumin and more.
A: Contact your Natural Field sales representative. Spec sheets and CoAs are compiled per requested items, samples are arranged by dosage-form needs, and joint-development projects are routed to technical teams.